CME Sponsor:
Practitioner’s Edge

Location:
This is an archived online CME webcast

Course Directors/Instructors:
Scott M. Fishman, MD
Chief, Division of Pain Medicine
Professor, Anesthesiology and Pain Medicine
University of California Davis School of Medicine
Sacramento, California

Richard C. Dart, MD, PhD
Director, Rocky Mountain Poison and Drug Center
Professor of Surgery, Pharmacy & Medicine
University of Colorado Health Sciences Center
Denver, Colorado

Nathaniel Katz, MD, MS
Adjunct Assistant Professor of Anesthesia
Tufts University School of Medicine
Boston, Massachusetts

Number of Credits:
1.25 AMA PRA Category 1 Credit(s)™
1.25 CNA/ANCC contact hour(s)
1.25 ACPE contact hour(s)

Registration Fee: Free

More Info

Detailed Description: 

Opioids provide effective pain management for patients with acute and moderate to severe chronic pain who have not responded adequately to other pain management therapies. However, prescription opioid abuse has escalated along with increased legitimate use in pain management. Because of potential prescription abuse, patients and physicians may be reluctant to initiate opioid therapy for pain relief. Currently, there are several novel strategies to assist in prevention of opioid misuse, abuse, and diversion. This highly interactive Practitioner’s Edge program will examine these novel clinical strategies in great detail. 

This session will feature a novel meeting format entitled Practitioner’s Edge. Practitioner's Edge provides an innovative, interactive approach to medical education featuring a multimedia presentation combining slides, video case studies, and audience response questions in a peer-to-peer discussion setting. The goal of Practitioner’s Edge is to provide practical tools and education that may be utilized immediately in daily practice.

Learning Objectives: 

  • Differentiate the concepts of opioid misuse, abuse, and diversion
  • Identify effective clinical strategies for preventing prescription opioid abuse, including diversion, while effectively managing patients with pain
  • Describe novel formulations aimed at decreasing risks for opioid misuse, abuse, and diversion